Trimethoprim/sulfamethoxazole
Trimethoprim/sulfamethoxazole, sold under the brand name Bactrim among others, is a fixed-dose combination antibiotic medication used to treat a variety of bacterial infections. It consists of one part trimethoprim to five parts sulfamethoxazole. It is used to treat urinary tract infections, methicillin-resistant Staphylococcus aureus (MRSA) skin infections, travelers' diarrhea, respiratory tract infections, and cholera, among others. It is used both to treat and prevent pneumocystis pneumonia and toxoplasmosis in people with HIV/AIDS and other causes of immunosuppression. It can be given orally (swallowed by mouth) or intravenous infusion (slowly injected into a vein with an IV).
Trimethoprim (top) and sulfamethoxazole (bottom) | |
Combination of | |
---|---|
Sulfamethoxazole | Sulfonamide antibiotic |
Trimethoprim | Dihydrofolate reductase inhibitor |
Clinical data | |
Trade names | Bactrim, Cotrim, Septra, others |
Other names | TMP/SMX, cotrimoxazole, Co-trimoxazole (BAN UK) |
AHFS/Drugs.com | Monograph |
License data | |
Pregnancy category |
|
Routes of administration | oral, intravenous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
(verify) |
Trimethoprim/sulfamethoxazole is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2021, it was the 122nd most commonly prescribed medication in the United States, with more than 4 million prescriptions.